Kevin Eisenfrats
Kevin co-founded Contraline and has been CEO since its inception. Contraline is a biotechnology company developing paradigm-shifting innovations... | Charlottesville, Virginia, United States
*50 free lookup(s) per month.
No credit card required.
Kevin Eisenfrats’s Emails ke****@co****.com
Kevin Eisenfrats’s Phone Numbers No phone number available.
Social Media
Kevin Eisenfrats’s Location Charlottesville, Virginia, United States
Kevin Eisenfrats’s Expertise Kevin co-founded Contraline and has been CEO since its inception. Contraline is a biotechnology company developing paradigm-shifting innovations in reproductive health, starting with the world's first long-lasting, reversible male contraceptive known as ADAM. Kevin has led Contraline from an idea to clinical-stage company, built a world-class team, and has brought in >25M in funding. Prior to Contraline, Kevin was involved in drug development in immuno-oncology and non-hormonal female contraception. He is an inventor on over 50 patents relating to novel contraceptive drugs, medical devices, and biomaterials. He has a degree in Nanomedicine Engineering from the University of Virginia, and in 2017, was named on the Forbes 30 Under 30 in Healthcare. Kevin is also an active angel investor and startup advisor, with a focus on biotech, deep tech, and women's health companies.
Kevin Eisenfrats’s Current Industry University Of Virginia Department Of Biomedical Engineering
Kevin
Eisenfrats’s Prior Industry
University Of Virginia
|
The National Institutes Of Health
|
Contraline
|
University Of Virginia Department Of Biomedical Engineering
Not the Kevin Eisenfrats you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
University Of Virginia Department Of Biomedical Engineering
Alumni Board
Fri Sep 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Contraline
Co-Founder and CEO
Sun Mar 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
The National Institutes Of Health
Research Associate
Thu May 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Virginia
Research Associate
Mon Oct 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)Skills
Languages
Kevin Eisenfrats Email Addresses
FAQ About Kevin Eisenfrats
-
Kevin Eisenfrats is located at
Charlottesville, Virginia, United States -
Kevin Eisenfrats is a
Kevin co-founded Contraline and has been CEO since its inception. Contraline is a biotechnology company developing paradigm-shifting innovations in reproductive health, starting with the world's first long-lasting, reversible male contraceptive known as ADAM. Kevin has led Contraline from an idea to clinical-stage company, built a world-class team, and has brought in >25M in funding. Prior to Contraline, Kevin was involved in drug development in immuno-oncology and non-hormonal female contraception. He is an inventor on over 50 patents relating to novel contraceptive drugs, medical devices, and biomaterials. He has a degree in Nanomedicine Engineering from the University of Virginia, and in 2017, was named on the Forbes 30 Under 30 in Healthcare. Kevin is also an active angel investor and startup advisor, with a focus on biotech, deep tech, and women's health companies. University Of Virginia Department Of Biomedical Engineering -
Kevin Eisenfrats currently works in the
University Of Virginia Department Of Biomedical Engineering -
Kevin Eisenfrats specializes in
Kevin co-founded Contraline and has been CEO since its inception. Contraline is a biotechnology company developing paradigm-shifting innovations in reproductive health, starting with the world's first long-lasting, reversible male contraceptive known as ADAM. Kevin has led Contraline from an idea to clinical-stage company, built a world-class team, and has brought in >25M in funding. Prior to Contraline, Kevin was involved in drug development in immuno-oncology and non-hormonal female contraception. He is an inventor on over 50 patents relating to novel contraceptive drugs, medical devices, and biomaterials. He has a degree in Nanomedicine Engineering from the University of Virginia, and in 2017, was named on the Forbes 30 Under 30 in Healthcare. Kevin is also an active angel investor and startup advisor, with a focus on biotech, deep tech, and women's health companies. -
Kevin Eisenfrats speaks the following languages:
No languages available. -
Kevin Eisenfrats has prior experience in the following industries:
The National Institutes Of Health , University Of Virginia -
Kevin Eisenfrats has the following professional experience:
University Of Virginia Department Of Biomedical Engineering , Contraline , The National Institutes Of Health , University Of Virginia . -
You can view Kevin Eisenfrats’s
LinkedIn profile at LinkedIn URL. -
Kevin Eisenfrats’s work email addresses are
[email protected] . -
Kevin Eisenfrats works at
University Of Virginia Department Of Biomedical Engineering
People you may be interested in
- Erik Goodin
- Ahmed Adel
- Jo Ann Hannigan
- Amanda Oldershaw
- Shirlyn D'costa
- Marc Owen
- Ryan Flenniken
- Patrick Oldfield
Manager, Technical Services Engineering
Diversey Consulting Manager (Food Safety & Quality Management Systems Consultant) (Approved Tutor by Highfield UK) Conducted more than 5,000 man-days Audits Train more than 10,000 trainees
manager at CARUSO MANAGEMENT GROUP
Community Events Officer
Student at Centennial College
Partner at Community Connect Marketing Investor in Ouachita Farms & LockerBlox Self Storage
Merchandising Supervisor at Keurig Dr Pepper
Investment Operations Specialist